Delivery Order SPE2DB22D1002-SPE2DB24FLDV3

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Naltrexone 50 mg tablets. The $5,204.37 firm fixed price contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,505.28 Firm Fixed Price Delivery Order is for the provision of Naltrexone 50mg in 30-count packages. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,586.59 firm fixed-price delivery order contract is for the supply of naltrexone 50 mg tablets to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, which covers a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,428.57 firm fixed-price delivery order is for the supply of 60-count bottles of 50 mg Naltrexone tablets. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,253.01, is for the delivery of 30 tablets of the drug Naltrexone 50 mg. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, with ID SPE2DX15D3402|SPE2DX25F1KAA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $2,422.98 firm fixed-price delivery order is for the supply of 4,566,066 Naltrexone 50 mg tablets in 60-count bottles. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded several indefinite delivery contracts (IDCs) by the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,262.38 for the supply of 30-count bottles of 50 mg Naltrexone tablets. The award was made by the Defense Logistics Agency (DLA) and does not include any set-aside designations, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award, valued at $1,182.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of pharmaceutical products, including prescription medications, over-the-counter drugs, and medical supplies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 50mg Naltrexone tablets. The contract has a firm fixed price of $2,257.92 with a period of performance through August 24, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a comprehensive range...
This federal contract award is for $3,415.65 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLDV3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $4,433.81, is for the delivery of Naltrexone 50 mg tablets to DLA facilities.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract award does not have a set-aside designation, indicating it was issued on a full and open competition basis. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for various agencies, including the Department of Defense and Department of Veterans Affairs.

Generated 9/19/24, 9:35 AM